FASIKL Trademark

Trademark Overview


On Tuesday, January 14, 2025, a trademark application was filed for FASIKL with the United States Patent and Trademark Office. The USPTO has given the FASIKL trademark a serial number of 98961823. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, June 19, 2025. This trademark is owned by Fasikl Inc.. The FASIKL trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, pulse generators for neurorecordation, neurosignal processing, neuromodulation, and neurostimulation
fasikl

General Information


Serial Number98961823
Word MarkFASIKL
Filing DateTuesday, January 14, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, June 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices, namely, pulse generators for neurorecordation, neurosignal processing, neuromodulation, and neurostimulation

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, January 14, 2025
Primary Code010
First Use Anywhere DateTuesday, June 6, 2023
First Use In Commerce DateTuesday, June 6, 2023

Trademark Owner History


Party NameFasikl Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBloomington, MN 55437

Trademark Events


Event DateEvent Description
Tuesday, January 14, 2025NEW APPLICATION ENTERED
Tuesday, January 14, 2025APPLICATION FILING RECEIPT MAILED
Friday, June 13, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 18, 2025ASSIGNED TO EXAMINER
Thursday, June 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 19, 2025NON-FINAL ACTION E-MAILED
Thursday, June 19, 2025NON-FINAL ACTION WRITTEN